Mer/Nyk/Eyk is an orphan receptor tyrosine kinase expressed at high levels in monocytes and cells derived from epithelial and reproductive tissues. Overexpression of Mer has been associated with lymphoid malignancies. Here we identify Gas6, the product of a growth arrest speci®c gene, as a ligand for Mer. Gas6 has previously been shown to activate both Axl and Rse/Tyro3, two other receptor tyrosine kinases in the same family as Mer. The apparent relative association and dissociation rate constants of Gas6 for soluble Axl, Rse/Tyro3 and Mer were compared using surface plasmon resonance. Gas6 was shown to induce rapid phosphorylation of Mer expressed in several dierent types of cells. We also observed a transient activation of p42 MAP kinase following activation of Mer by Gas6. Thus, Gas6 exerts its biological eects through multiple receptor tyrosine kinases.
Introduction
Mer, Rse and Axl comprise a family of tyrosine kinase receptors whose disregulated expression is associated with cellular transformation. For example, Mer was cloned from a neoplastic B cell line and is expressed in numerous transformed T acute lymphocytic leukemia cell lines (Graham et al., 1994) . It was independently isolated as a tyrosine kinase potentially involved in the development of glioblastomas, and called Nyk (for NCAM-related tyrosine kinase; Ling and Kung, 1995) . The transforming gene of the avian retrovirus RPL30, v-eyk, was derived from the chicken homologue of Mer, c-eyk (Jia and Hanafusa, 1994) . Axl was isolated from DNA of patients with chronic myelogenous leukemia (O'Bryan et al., 1991) and chronic myeloproliferative disorder (Janssen et al., 1991) using a transfection/tumorogenicity assay. Rse (Mark et al., 1994, also known as brt, sky, tyro3, etk2 and tif, Fujimoto and Yamamoto, 1994; Ohashi et al., 1994; Lai and Lemke, 1994; Biesecker et al., 1995; Dai et al., 1994) and Axl, when overexpressed in ®broblasts and certain hematopoietic cells induce cellular transformation (Taylor et al., 1995; O'Bryan et al., 1991; McCloskey et al., 1994) . Rse mRNA and protein are also overexpressed in mammary tumors derived from transgenic animals that overexpress either the wnt-1 or fgf-3 oncogenes (Taylor et al., 1995) .
The mRNAs for Axl and Mer and Rse exhibit distinct but overlapping patterns of expression and are widely expressed in cells of the hematopoietic system. Mer mRNA is detected in peripheral blood mononuclear cells, bone marrow mononuclear cells and monocytes, but not in granulocytes. Despite the fact that Mer mRNA is expressed in neoplastic B and T cell lines, it is not detected in normal B or T lymphocytes (Graham et al., 1994) . Like Mer, Axl is expressed in monocytes but not in granulocytes or mature B or T lymphocytes (Neubauer et al., 1995) . Rse mRNA was detected in a megakaryocytic cell line (Mark et al., 1994) . In normal human tissues, Rse mRNA is expressed preferentially in the adult brain and at lower levels in kidney, ovary, and testis (Mark et al., 1994) . Axl and Mer are also widely expressed, but the highest levels of Axl mRNA are found in the heart and skeletal muscle (Neubaure et al., 1995) while Mer mRNA is expressed at highest levels in ovary, prostate, lung and kidney (Graham et al., 1994) .
The extracellular domains of the Rse/Axl/Mer family of receptors contain 28 ± 36% amino acid identity and are composed of two immunoglobulin (Ig) repeats followed by two membrane proximal ®bronectin type three (Fn-III) repeats. This combination of structural motifs within the extracellular domains of Rse, Axl and Mer is similar to that observed in neural cell adhesion molecules (Brummendorf and Rathjen, 1993; Rutishauser, 1993) .
We have shown that Gas6 is a ligand for human Rse (Godowski et al., 1995) . Gas6 binds directly to Rse, and rapidly stimulates phosphorylation of the receptor in a dose responsive fashion (Godowski et al., 1995; Mark et al., 1996) . This work has been independently con®rmed by Ohashi et al. (1995) . Interestingly, Varnum et al. (1995) identi®ed Gas6 as a ligand for human Axl. This work was con®rmed independently (Stitt et al., 1995; Mark et al., 1996) .
Gas6 was initially identi®ed as a product of a gene whose expression is increased in ®broblasts upon growth arrest (Man®oletti et al., 1993) . Gas6 contains 46% amino acid identity and a similar domain organization with Protein S, an abundant serum protein and a negative regulator of the coagulation cascade (Dahlback et al., 1986) . Although human Protein S has been reported to activate murine Rse (Stitt et al., 1995) , it does not activate human Rse (Godowski et al., 1995; Ohashi et al., 1995; Mark et al., 1996) . The amino-terminal Gla domain of Gas6 is rich in g-carboxyglutamic acid (Gla) residues. Gla domains commonly serve to mediate the Ca 2+ dependent binding of proteins to negatively charged phospholipids present in cell membranes. A loop region and four EGF-like repeats follow the Gla domain. The loop region of Protein S contains thrombin-sensitive cleavage sites, although these are not conserved in Gas6. The C-terminal portions of Gas6 and Protein S are similar to the steroid hormone binding globulin (SHBG) protein (Gershagen et al., 1987; Hammond et al., 1987) and contain tandem globular' or G domains. G domains were initially characterized in laminin A chain and are also present in numerous proteins involved in cell growth and dierentiation (reviewed by Joseph and Baker, 1992; Patthy and Nikolics, 1993) . The G domains of Gas6 are sucient to bind with high anity to Rse and to Axl and can activate receptor phosphorylation with a speci®c activity similar to that of the full length molecule (Mark et al., 1996) .
In this report we characterize the interaction of Mer with Gas6 and Protein S. Our results suggest that a single protein serves as a ligand for all three identi®ed members of the Rse/Axl/Mer receptor family. We provide evidence that Gas6 induced activation of Mer results in activation of the MAP kinase pathway.
Results

Comparison of Gas6 and protein S binding to the extracellular domains of Mer
We constructed, expressed and puri®ed a soluble form of the extracellular domain of Mer (termed Mer-Fc). Similar fusion proteins derived from the extracellular domains of Rse (Rse-Fc) or Axl (Axl-Fc) have been shown to bind with high anity to Gas6 (Godowski et al., 1995; Mark et al., 1996) . As an initial test to ascertain whether Mer bound Gas6, we compared the ability of Mer-Fc and Rse-Fc to neutralize the Gas6 induced phosphorylation of Rse in an ELISA based KIRA assay. Activation of Rse by Gas6 was blocked by Rse-Fc and Mer-Fc, but not by control Fc protein, in a dose-responsive fashion (Figure 1 ). These data suggest that Mer-Fc, like Rse-Fc, competitively inhibits activation of Rse by binding to Gas6. We note that Rse-Fc was somewhat more potent than Mer-Fc in neutralizing Gas6. This result is consistent with the dierences in anity of these proteins for Gas6 as described.
We then compared the ability of Axl-, Rse-and Mer-Fc to bind directly to Gas6 using a coprecipitation assay. We also determined if these receptors bound Protein S, which contains 46% amino acid identity with Gas6. To allow a more quantitative comparison of their binding properties, we utilized versions of Gas6 and Protein S that contained epitope tags (Godowski et al., 1995) . Conditioned media from cells expressing tagged Gas6 or Protein S was incubated with each of the receptor fusion proteins. The Fc fusion proteins, and proteins bound to them, were recovered with protein A and washed extensively. Tagged proteins that bound to the Fc-fusion proteins were revealed by Western blotting and detection with an antibody directed against the epitope tag. As observed previously, both Axl-Fc and Rse-Fc bound tagged Gas6 but not Protein S (Figure 2 ). An identical result was observed with Mer-Fc. The binding was speci®c in that neither Gas6 nor Protein S bound the control CD4-Fc.
Surface plasmon resonance was used to further characterize interactions of Mer with potential ligands. Mer-Fc was covalently coupled through amino groups to dextran immobilized on the gold surface of a biosensor chip. Potential ligands were injected over the chip, and their association and dissociation with Mer was measured by recording the changes in the refraction of polarized light and the angle of the absorption maximum by the plasmon electrons of the gold ®lm. A representative sensorgram from an experiment in which two dierent concentrations of Gas6 were passed over the chip is shown in Figure 3a . As Gas6 was injected over the chip, association with Mer was measured as a gradual increase in the RU (resonance units) over time; following the injection, the resonance slowly decreased as Gas6 dissociated from Mer. In contrast, injection of Protein S resulted in a sample bulk eect, a sudden apparent increase in RU at the beginning of the injection. After injection, the RU dropped immediately back to the baseline level, indicating that Protein S did not bind with a The kinetics of binding of Gas6 to the extracellular domains of Mer, Axl and Rse were compared by surface plasmon resonance. In each case we observed a single class of binding sites for Gas6 with the receptor. The association rate of Gas6 with soluble Axl was more rapid compared to those observed with either Rse or Mer (Table 1) . While the dissociation rates of Gas6 from Axl and Rse were similar, Gas6 dissociated more rapidly from Mer. Consequently, the equilibrium dissociation constant (K D ) of Gas6 with Mer was higher than that observed for either Axl or Rse.
Mer is phosphorylated in response to Gas6 and agonistic antibodies
We used a polyclonal antibody developed against the extracellular domain of Mer and¯uorescence activated cell sorting to demonstrate that human embryonic kidney 293 cells express Mer (data not shown). Activation of the intrinsic kinase activity of a receptor can often be achieved by incubation of intact cells with anti-receptor antibodies that promote receptor oligomerization. We took advantage of this fact to characterize Mer in 293 cells. Following treatment of intact cells with a-Mer antibody, we observed rapid phosphorylation of a protein which migrated with a molecular weight of approximately 200 kDa ( Figure  4a ). The size of this protein is consistent with the observation that Mer contains a number of sites for Nlinked glycosylation, and is glycosylated (unpublished observations). As a control, we showed that the 200 kDa protein did not become phosphorylated in 293 cells treated with an agonistic a-Rse antibody; in this case, a 140 kDa protein that migrates with the size expected for Rse was phosphorylated on tyrosine. These results suggest that Mer is expressed as a 200 kDa protein in 293 cells and that the tyrosine kinase domain is functional.
We next compared the abilities of puri®ed human Gas6 and Protein S to act as activating ligands for Mer. Consistent with the binding studies, incubation of cells with Gas6 but not Protein S results in the phosphorylation of a 200 kDa protein that is immunoprecipitated with a-Mer antibody (Figure 4a ).
Because our a-Mer antibody reacted poorly with Mer on Western blots, we performed an additional experiment to establish unequivocally that the 200 kDa protein is Mer. We constructed and expressed a version of Mer, termed gD.Mer, which contains an amino terminal epitope tag. As shown previously for a similarly tagged version of Rse (gD.Rse; Mark et al., 1994) , incubation of 293.gD.Mer cells with an antibody speci®c for the epitope tag results in phosphorylation of a 200 kDa protein that was precipitated with antibodies to the epitope tage ( Figure 4b ). As observed with untagged Mer, gD.Mer was activated Mer is highly expressed in cells derived from the monocyte cell lineage and Mer mRNA is detected in the monocytic cell line U937 (Graham et al., 1994) . We con®rmed that U937 cells express Mer protein at their surface by FACS analysis (data not shown). We further characterized the properties of Gas6 as a ligand for Mer in these cells. A time course experiment demonstrated that Mer is rapidly activated in these cells (Figure 5a) , with maximal phosphorylation observed within 1 ± 10 min following addition of ligand. In a dose response experiment, phosphorylation of Mer was detected at concentrations of Gas6 of *5 ± 10 nM (Figure 5b ).
Phosphorylation of MAP kinase in 293 cells in response to Gas6 and a-Mer agonistic antibody
We examined the cellular events induced by treatment of 293 cells with Gas6. Activation of receptor tyrosine kinases is often associated with phosphorylation and activation of the mitogen activated protein (MAP) kinase pathway. Therefore, we examined if Gas6 treatment of serum starved 293 cells resulted in phosphorylation of MAP kinase. Whole cell extracts were prepared from Gas6 activated 293 cells and immunoblots were probed with antibodies speci®cally against tyrosine-phosphorylated forms of MAP kinase. p42MAPK and p44MAPK were seen to become phosphorylated as early as 2 min post Gas6 stimulation ( Figure 6 ). The kinetics of activation of MAP kinase correlates well with the rapid induction of phosphorylation of Mer following Gas6 treatment in these cells.
Gas6 activates both Rse and Mer in 293 cells. Thus, the activation of MAPK in these cells in response to Gas6 could be mediated by either Rse or Mer or a combination of these receptors. As a ®rst step in discerning the contributions of Mer to activation of downstream signaling events, we examined if activation of Mer by the a-Mer agonistic antibody also resulted in subsequent phosphorylation of MAP kinase. We observed that both p42MAPK and p44MAPK became phosphorylated within 2 min following stimulation of Mer with antibody. These results further support a model where activation of Mer in 293 cells leads to downstream activation of the MAP kinase pathway. 
Discussion
These observations show that Gas6 is a functional ligand for Mer. Previous studies have demonstrated that Gas6 is also a ligand for two other members of this receptor tyrosine kinase family, Rse (Godowski et al., 1995; Ohashi et al., 1995; Mark et al., 1996) and Axl (Varnum et al., 1995; Stitt et al., 1995) . In each case, Gas6 has been shown to bind directly to the extracellular domains of the receptor in vitro and stimulate phosphorylation of the receptors in vivo. The biological rationale for Gas6 serving as a ligand for Rse, Axl and Mer is not yet clear but precedents for this phenomenon exist. Vascular endothelial growth factor (VEGF) is a ligand for at least two receptor tyrosine kinases, Flt-1 and Flk-1. Both receptors are expressed in endothelial cells. The phenotypes of mice containing targeted mutations in Flt-1 or Flk-1 are dierent, suggesting that the roles of these receptors are not redundant (Fong et al., 1995; Shalaby et al., 1995) . The Eph related receptors consist of a large family of tyrosine kinases. At least seven ligands have been identi®ed for Eph-related receptors. These ligands exhibit promiscuity in that dierent ligands often bind to multiple members of the Eph receptor family. A set of closely related proteins known as neuregulins act as ligands for the erB gene family which includes the EGF receptor, erbB-2, erbB-3 and erbB-4. The physiological response of a particular cell to the neuregulins is governed by the complex interactions of dierent erbB family members expressed in that cell. For example, neuregulin does not bind erbB-2, but does bind erbB-3 and erbB-4. However, erbB-2 can be activated by neuregulins because it forms heterodimers with erbB-3 and erbB-4 (Sliwkowski et al., 1994; Riese et al., 1995) . The anity of Gas6 for the puri®ed extracellular domain of Mer-Fc was lower than that observed for Gas6 with Rse-Fc or Axl-Fc. Moreover, the anities we (Table 1 and reefs 15 and 16) and others (17 ± 19) have reported for Gas6 for the extracellular domains of these receptors (K d =1 ± 9 nM) are not as high as those observed for many other growth factor-receptor combinations. The anities we determined in vitro may dier from those of Gas6 for Rse, Axl and Mer expressed on cell surfaces. It is worth noting that the binding anity of the neuregulins for either erbB-3 or erbB-4 homodimers is similar to what we have reported for Gas6 with the Axl/Rse/Mer family. Interestingly, the anity of neuregulins for erbB-3 and erbB-4 is increased 4100-fold by heterodimerization of these receptors with erbB-2. While there is no direct evidence that Rse, Axl or Mer form heterodimers, the receptors do exhibit overlapping patterns of expression. We detect expression of Rse and Axl in primary human Schwann cells (Li et al., 1996) , and Rse and Mer are both expressed in 293 cells and U937 cells (Figures 4  and 5 ). Gas6 treatment of 293 or U937 cells results in phosphorylation of both Mer and Rse. Since it is not known if these receptors can heterodimerize, we do not know if the phosphorylation we observe is due to trans-or autophosphorylation. Gas6 has been reported to block apoptosis induced by growth arrest in rat vascular smooth muscle cells (Nakano et al., 1996) . However, it was not determined if this function of Gas6 is mediated by Rse, Axl or Mer (or combinations of these receptors) since the receptor status of these cells was not examined. As noted above, the expression of Rse, Axl and Mer is often overlapping. This may present a mechanism to modulate both quantitatively and qualitatively the range of biological responses mediated by Gas6.
Since the ligand for Mer had not previously been reported, earlier studies of the signaling pathways regulated by Mer have relied on the use of chimeric receptors. For example, an arti®cial construct containing the ligand binding domain of the colonystimulating factor 1 receptor (Fms) and the Mer intracellular domain was shown to activate MAP kinase in a CSF-1 dependent manner (Ling and Kung, 1995) . Zong et al. (1996) showed that the intracellular domain of the avian homologue of Mer, c-Eyk, stimulates the JAK-STAT pathway but not the Ras-MAP kinase or JNK pathways. In this latter case, the kinase domain of c-eyk was constitutively activated by construction of chimeric CD-8/c-eyk fusion gene. While chimeric receptors have been widely used to study intracellular signaling events, there are examples when the signaling response of the kinase domain is dramatically altered by the extracellular domain. For example, Fridell et al. (1996) demonstrated that a chimeric receptor containing the extracellular domain of the EGF receptor and the kinase domain of Axl activated MAP kinase in a ligand dependent fashion in 32D cells. However, authentic Axl did not activate MAP kinase in these cells in response to its cognate ligand Gas6. The molecular mechanisms involved in the dierential activation of intracellular signaling pathways by chimeric and natural Axl is not understood. As suggested by Fridell (1996) The observation that Gas6 is a ligand for Mer should facilitate studies aimed at elucidating the intracellular signaling mechanisms activated by this receptor and perhaps provide clues to the mechanism by which Mer induces transformation.
Materials and methods
Construction and expression of recombinant proteins
A cDNA encoding human Mer was obtained by screening a human testis cDNA library prepared in lambda DR2 (Clontech, Palo Alto CA) with oligonucleotide probes 5'-GAAA TTACAGATCCGCAG CCC CGGGATGGGGCC -GGCCCCGCTGCCGCTGC, 5'-CCTTGGATTCTAGCA-AGCA CGACT GAAGG AG CCCCATCAGTAGCACCT -TT and 5'-TCTTAAAATTAAGCTTCAGCTGCTCCT-TGATATTAACCTTTGTACAGAGT-3'). Positive phage were puri®ed and insert sizes were determined. Fragments from three overlapping clones, hMer.cl4, hMer.cl25, and hMer.cl6 (corresponding to nucleotides 1 ± 561, 223 ± 2025, and 1902 ± 3608, respectively, of the sequence published by Graham et al., 1994) were combined to make a cDNA encoding the entire open reading frame of human Mer.
Mer-Fc was constructed by fusing the sequence encoding amino acids 1 ± 498 of human Mer to amino acids 216 ± 443 of human IgG g1 through a Narl ± BstEll linker (5'-CGCCTGGCAACGCG-3', 5'-GTGACCGCGTTGCCAG-3') (adding amino acids valine and threonine). Human embryonic kidney (HEK) 293 cells expressing Mer-Fc were screened using a human Fc-speci®c ELISA. Mer-Fc was puri®ed on a protein A-sepharose column (Pharmacia).
Epitope tagged gD.Mer was constructed by fusing the coding sequences for amino acids 1 ± 53 of herpes simplex virus type 1 (HSV I) glycoprotein D (gD) to the sequences encoding amino acids 36 ± 999 of human Mer. This contains the HSV-1 gD signal sequence as well as an epitope for monoclonal antibody 5B6 (Paborsky et al., 1990) . Oligos (5'-CGAATTCCTCGAGCCGGGACC TTTT CCA GGG AGC -3', and 5'-CCAACTGTGTGTTTGAAGGCAAGAGGCGG-3') were used to add a Xhol site to the human Mer cDNA by PCR. The gD-Mer cDNA was inserted into a CMV-based expression vector and HEK 293 cells were transfected, selected and screened by Western blotting and¯uorescent activated cell sorting as described (Mark et al., 1994) .
Recombinant human Gas6 and Protein S were expressed as described (Godowski et al., 1995 (Mark et al., 1992) and/or by Western blotting with a rabbit polyclonal a-Gas6 antiserum or rabbit a-Protein S antiserum (Sigma). N-terminal gD-tagged versions of Protein S or Gas6 have been described previously (Mark et al., 1996) .
Phosphorylation assays
CHO.Rse.gD cells and methods to detect Rse phosphorylation using the ELISA based KIRA assay and by Western analysis using anti-phosphotyrosine antibodies have been described (Godowski et al., 1995; Mark et al., 1996) . For neutralization experiments, potential ligand sources were treated at room temperature for 30 min with the indicated Fc fusion protein prior to addition to cells. To analyse the ability of potential ligands to induce phosphorylation of receptors in 293 cells, 100 000 cells were seeded on a 60 mm dish in the presence of serum for 16 h. The cells were then washed twice in PBS and serum-starved for 6 h. Potential ligands were added to the cells and receptors were immunoprecipitated from lysates, analysed by SDS ± PAGE under reducing conditions and blotted with anti-phosphotyrosine antibody (4G10; Upstate Biotechnology Company) as described (Mark et al., 1994) . For experiments involving U937 cells were starved for serum for 16 h and 2 000 000 cells were treated with Gas6 or polyclonal a-Mer antibody as indicated in the ®gure legend. Cell lysates were prepared and treated as described above.
MAP kinase was detected on Western blots of whole cell lysates using antibodies speci®c for tyrosine phosphorylated and unphosphorylated forms of MAP Kinase from New England Biolabs, and detected with a goat anti-rabbit HRP conjugated antibody (Sigma).
Binding assays
For binding to Rse-Fc, Axl-Fc, and Mer-Fc, conditioned media containing 300 nM Gas6 or Protein S were precleared with protein A-sepharose (Sigma) for 30 min at room temperature, then incubated with 5 mg of receptorFc fusion protein for 4 h at 48C. Fusion proteins were immunoprecipitated with 20 ml of protein A-sepharose and the complexes were collected by centrifugation at 14 000 g for 1 min, and then washed three times with PBS containing 0.1% Triton X-100. Precipitates were analysed by SDS ± PAGE under reducing conditions. Western blots of the SDS ± PAGE gels were probed with antibody 5B6 as described (4).
Protein interaction analyses using BIAcore TM instruments were performed with receptor-Fc proteins coupled to BIAcore CM5 sensor chips using puri®ed Gas6 and Protein S as described (Mark et al., 1996) . For neutralization experiments, 5 mg of either Mer-Fc or CD4-Fc was mixed with Gas6 for 30 min at room temperature prior to injection of the mixture over the chip. Sensorgrams were analysed with BIAevaluation 2.1 software from Pharmacia Biosensor AB. Apparent dissociation rate constants (k d ) and association rate constants (k a ) were obtained by evaluating the sensorgram with A+B=AB type I ®tting. The equilibrium dissociation constant K d was calculated as kd/ka.
